| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9306 |
Injection, pertuzumab, 1 mg |
90 |
63 |
$544K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
266 |
188 |
$339K |
| Q5114 |
Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg |
77 |
53 |
$196K |
| J9271 |
Injection, pembrolizumab, 1 mg |
19 |
14 |
$181K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,567 |
1,015 |
$67K |
| 96367 |
|
769 |
510 |
$39K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
950 |
915 |
$38K |
| 96417 |
|
771 |
496 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,096 |
719 |
$24K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
25 |
25 |
$20K |
| 96368 |
|
554 |
334 |
$9K |
| 96415 |
|
176 |
128 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
264 |
186 |
$6K |
| 99215 |
Prolong outpt/office vis |
75 |
67 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
73 |
66 |
$4K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
306 |
177 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
32 |
32 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
352 |
272 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
854 |
534 |
$2K |
| J1453 |
Injection, fosaprepitant, 1 mg |
61 |
39 |
$1K |
| 96402 |
|
59 |
56 |
$507.59 |
| J3489 |
Injection, zoledronic acid, 1 mg |
13 |
12 |
$313.89 |
| 36415 |
Collection of venous blood by venipuncture |
863 |
698 |
$125.40 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
83 |
45 |
$90.19 |